Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial.
暂无分享，去创建一个
J. Bourhis | A. Hagemeijer | F. Mandelli | G. Leone | R. Willemze | R. Zittoun | B. Labar | S. Suciu | S. Amadori | P. Fazi | G. Fioritoni | U. Jehn | R. Delarue | G. De Rosa | V. Liso | E. Gallo | S. Mirto | R. Giustolisi | A. Belhabri | T. D. de Witte